Description
Ambroxol is a mucolytic agent that causes increased secretion of the respiratory tract. It causes increasing production of pulmonary surfactant and stimulates ciliary activity. As a result, there is an increasing of mucus flow and transport (mucoceles clearance) and facilitation of the expectoration and cough.
Indications
– Secretolytic therapy of acute and chronic bronchopulmonary diseases associated with defective secretion and transport of bronchial mucous.
Subject to medical prescription
Pharmaceutical form: 30 mg x 20 effervescent tablets
